Publications by authors named "Slawomir Jasek"
Article Synopsis
- The study investigates the presence and burden of coronary artery calcium (CAC) in cancer patients undergoing anthracycline chemotherapy, assessing cardiovascular risks associated with cancer treatment.
- A total of 80 patients were included, with most being diagnosed with breast cancer and categorized into moderate and high-risk groups for chemotherapy-related cardiovascular toxicity.
- Results showed that high-risk patients had significantly higher CAC scores, elevated cardiac biomarkers, and more common diastolic dysfunction, despite similar left ventricle ejection fractions compared to moderate-risk patients.
Background: Cardiological complications of oncological treatment, including the most serious one, heart failure, constitute a significant and still unsolved clinical problem. A history of dyslipidemia and complications of atherosclerosis, including coronary artery disease, are established risk factors for cardiotoxicity in cancer patients. In recent years, a protective effect of statin treatment on the development of heart failure in cancer patients has been observed.
View Article and Find Full Text PDFBackground: Interventional treatment improves prognosis in patients with acute coronary syndromes (ACS). However, despite introduction of percutaneous coronary intervention (PCI), the risk of cardiovascular events in patients with multivessel coronary artery disease (MVD) remains significant.
Aim: To evaluate the risk of complications and the prognostic value of MVD in patients with ACS during 1-year follow-up.